Inhalation of hydrogen gas reduces exacerbations of acute aortic dissection in mice.
Masumi Iketani, Mitsuhiro Kawata, Masafumi Ito, Ikuroh Ohsawa, Kenichi Takayama, Toshiyuki Aokage · Life sciences · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In bone marrow, the reduction in CD11b+Ly-6G+ neutrophils observed in AAD mice was significantly attenuated by H₂ inhalation. In the aortic wall, H₂ reduced MMP-9 and CXCL1 expression, including within Ly-6B.2-positive regions, whereas CXCL1 expression within SMA-positive regions was unchanged. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in mice. In bone marrow, the reduction in CD11b+Ly-6G+ neutrophils observed in AAD mice was significantly attenuated by H₂ inhalation.
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 2% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 2% source-reported H₂ gas concentration. In bone marrow, the reduction in CD11b+Ly-6G+ neutrophils observed in AAD mice was significantly attenuated by H₂ inhalation. The authors concluded that these findings indicate that 2% H₂ gas inhalation reduces acute AAD exacerbation without affecting blood pressure, likely through modulation of inflammatory mediators and neutrophil-associated acute inflammation.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 2% source-reported H₂ gas concentration.
Limitations and Safety
Safety information: H₂ inhalation may represent a safe adjunctive strategy to limit AAD progression and rupture.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.